BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 1672289)

  • 41. Hereditary medullary thyroid carcinoma.
    Vasen HF; Vermey A
    Cancer Detect Prev; 1995; 19(2):143-50. PubMed ID: 7750101
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Closing in on the MEN2A locus.
    Simpson NE; Kidd KK
    Henry Ford Hosp Med J; 1989; 37(3-4):100-5. PubMed ID: 2576936
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Familial medullary thyroid carcinoma: not a distinct entity? Genotype-phenotype correlation in a large family.
    Moers AM; Landsvater RM; Schaap C; Jansen-Schillhorn van Veen JM; de Valk IA; Blijham GH; Höppener JW; Vroom TM; van Amstel HK; Lips CJ
    Am J Med; 1996 Dec; 101(6):635-41. PubMed ID: 9003111
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mapping the inherited defects associated with multiple endocrine neoplasia type 2A, multiple endocrine neoplasia type 2B, and familial medullary thyroid carcinoma to chromosome 10 by linkage analysis.
    Goodfellow PJ
    Endocrinol Metab Clin North Am; 1994 Mar; 23(1):177-85. PubMed ID: 7913024
    [No Abstract]   [Full Text] [Related]  

  • 45. RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma.
    Marsh DJ; Mulligan LM; Eng C
    Horm Res; 1997; 47(4-6):168-78. PubMed ID: 9167949
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical manifestations of familial medullary thyroid carcinoma.
    Kameyama K; Okinaga H; Takami H
    Biomed Pharmacother; 2004; 58(6-7):348-50. PubMed ID: 15271414
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multiple endocrine neoplasia 2 (MEN 2)/MEN 2A (Sipple syndrome).
    Kousseff BG
    Dermatol Clin; 1995 Jan; 13(1):91-7. PubMed ID: 7712656
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preoperative diagnosis of occult parathyroid hyperplasia by calcium infusion in patients with multiple endocrine neoplasia, type 2a.
    Heath H; Sizemore GW; Carney JA
    J Clin Endocrinol Metab; 1976 Aug; 43(2):428-35. PubMed ID: 950371
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Multiple endocrine neoplasms type 2. Recent aspects].
    Guillausseau PJ; Calmettes C; Feingold N; Franc B; Guillausseau-Scholer C; Modigliani E; Sobol H
    Presse Med; 1991 Dec 21-28; 20(44):2256-62. PubMed ID: 1685777
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiple endocrine neoplasia.
    Caruso DR; O'Dorisio TM; Mazzaferri EL
    Curr Opin Oncol; 1991 Feb; 3(1):103-8. PubMed ID: 1675123
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.
    Kinlaw WB; Scott SM; Maue RA; Memoli VA; Harris RD; Daniels GH; Porter DM; Belloni DR; Spooner ET; Ernesti MM; Noll WW
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Deletion mapping on the distal third region of chromosome 1p in multiple endocrine neoplasia type IIA.
    Yang KP; Nguyen CV; Castillo SG; Samaan NA
    Anticancer Res; 1990; 10(2B):527-33. PubMed ID: 1972009
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multiple endocrine neoplasia syndrome type 2: the value of screening and central registration. A study of 15 kindreds in The Netherlands.
    Vasen HF; Nieuwenhuijzen Kruseman AC; Berkel H; Beukers EK; Delprat CC; Van Doorn RG; Geerdink RA; Haak HR; Hackeng WH; Koppeschaar HP
    Am J Med; 1987 Nov; 83(5):847-52. PubMed ID: 2890300
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic testing in presymptomatic diagnosis of multiple endocrine neoplasia.
    Calender A; Giraud S; Schuffenecker I; Lenoir GM; Gaudray P; Courseaux A; Porchet N; Aubert JP; Zhang CX
    Horm Res; 1997; 47(4-6):199-210. PubMed ID: 9167953
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Loss of genes on chromosome 22 in medullary thyroid carcinoma and pheochromocytoma.
    Takai S; Tateishi H; Nishisho I; Miki T; Motomura K; Miyauchi A; Kato M; Ikeuchi T; Yamamoto K; Okazaki M
    Jpn J Cancer Res; 1987 Sep; 78(9):894-8. PubMed ID: 2889715
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early detection of hereditary medullary thyroid cancer with polymorphic DNA probes. Groupe d'Etude des Tumeurs a Calcitonine.
    Narod SA; Sobol H; Schuffenecker I; Ezekowitz RA; Lenoir GM
    Henry Ford Hosp Med J; 1989; 37(3-4):106-8. PubMed ID: 2576937
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiple endocrine neoplasia type 2B (mucosal neuroma syndrome, Wagenmann-Froboese syndrome).
    Morrison PJ; Nevin NC
    J Med Genet; 1996 Sep; 33(9):779-82. PubMed ID: 8880581
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chromosome 20 deletion in human multiple endocrine neoplasia types 2A and 2B: a double-blind study.
    Babu VR; Van Dyke DL; Jackson CE
    Proc Natl Acad Sci U S A; 1984 Apr; 81(8):2525-8. PubMed ID: 6585814
    [TBL] [Abstract][Full Text] [Related]  

  • 59. One large kindred excludes a locus for multiple endocrine neoplasia type 2A from about 25% of the human autosomal genetic map.
    Pakstis AJ; Kidd JR; Castiglione CM; Pletcher BA; Murphy PD; Farrer LA; Genel M; Kidd KK
    Henry Ford Hosp Med J; 1987; 35(2-3):164-7. PubMed ID: 2891651
    [No Abstract]   [Full Text] [Related]  

  • 60. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
    Sansó G; Domené HM; Iorcansky S; Barontini M
    Medicina (B Aires); 1998; 58(2):179-84. PubMed ID: 9706252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.